Murray Stahl's CME Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 275,611 shares of CME Group Inc. (CME) worth $75.26 M, representing 1.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in CME, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2017, adding 204,542 shares. Largest reduction occurred in Q2 2024, reducing 58,788 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1,162 | Reduce 0.42% | 275,611 | $273.08 |
| Q3 2025 | +149,375 | Add 117.25% | 276,773 | $270.19 |
| Q2 2025 | -855 | Reduce 0.67% | 127,398 | $275.62 |
| Q1 2025 | +2,400 | Add 1.91% | 128,253 | $265.29 |
| Q4 2024 | -2,860 | Reduce 2.22% | 125,853 | $232.23 |
| Q3 2024 | -11,899 | Reduce 8.46% | 128,713 | $220.65 |
| Q2 2024 | -58,788 | Reduce 29.48% | 140,612 | $196.60 |
| Q1 2024 | -1,330 | Reduce 0.66% | 199,400 | $215.29 |
| Q4 2023 | -19,246 | Reduce 8.75% | 200,730 | $210.60 |
| Q3 2023 | -11,451 | Reduce 4.95% | 219,976 | $200.22 |
| Q2 2023 | -9,160 | Reduce 3.81% | 231,427 | $185.29 |
| Q1 2023 | -4,087 | Reduce 1.67% | 240,587 | $191.52 |
| Q4 2022 | -7,488 | Reduce 2.97% | 244,674 | $168.16 |
| Q3 2022 | -11,987 | Reduce 4.54% | 252,162 | $177.13 |
| Q2 2022 | +18,474 | Add 7.52% | 264,149 | $204.70 |
| Q1 2022 | +34,753 | Add 16.48% | 245,675 | $237.86 |
| Q4 2021 | +8,798 | Add 4.35% | 210,922 | $228.46 |
| Q3 2021 | +2,008 | Add 1.00% | 202,124 | $193.38 |
| Q2 2021 | +39,478 | Add 24.58% | 200,116 | $212.68 |
| Q1 2021 | +7,738 | Add 5.06% | 160,638 | $204.23 |
| Q4 2020 | -18,164 | Reduce 10.62% | 152,900 | $182.05 |
| Q3 2020 | -11,541 | Reduce 6.32% | 171,064 | $167.31 |
| Q2 2020 | -5,838 | Reduce 3.10% | 182,605 | $162.54 |
| Q1 2020 | -7,972 | Reduce 4.06% | 188,443 | $172.91 |
| Q4 2019 | -8,211 | Reduce 4.01% | 196,415 | $200.72 |
| Q3 2019 | -3,637 | Reduce 1.75% | 204,626 | $211.34 |
| Q2 2019 | -9,563 | Reduce 4.39% | 208,263 | $194.11 |
| Q1 2019 | -8,205 | Reduce 3.63% | 217,826 | $164.58 |
| Q4 2018 | +2,744 | Add 1.23% | 226,031 | $188.12 |
| Q3 2018 | -4,230 | Reduce 1.86% | 223,287 | $170.21 |
| Q2 2018 | +4,595 | Add 2.06% | 227,517 | $163.92 |
| Q1 2018 | +8,924 | Add 4.17% | 222,922 | $161.74 |
| Q4 2017 | +204,542 | Add 2163.09% | 213,998 | $146.05 |
| Q2 2017 | -165 | Reduce 1.71% | 9,456 | $125.21 |
| Q1 2017 | +6 | Add 0.06% | 9,621 | $118.80 |
| Q3 2016 | -1 | Reduce 0.01% | 9,615 | $104.52 |
| Q1 2016 | -1,260 | Reduce 11.59% | 9,616 | $95.99 |
| Q4 2015 | -48,760 | Reduce 81.76% | 10,876 | $90.57 |
| Q3 2015 | -11,990 | Reduce 16.74% | 59,636 | $92.75 |
| Q2 2015 | -400 | Reduce 0.56% | 71,626 | $93.05 |
| Q4 2014 | -73 | Reduce 0.10% | 72,026 | $88.65 |
| Q3 2014 | -1,170 | Reduce 1.60% | 72,099 | $79.96 |
| Q2 2014 | -4,730 | Reduce 6.06% | 73,269 | $70.96 |
| Q1 2014 | -1,056 | Reduce 1.34% | 77,999 | $74.01 |
| Q4 2013 | -431 | Reduce 0.54% | 79,055 | $78.46 |
| Q3 2013 | -2,447 | Reduce 2.99% | 79,486 | $73.87 |
| Q2 2013 | +81,934 | Add 0.00% | 81,933 | $75.95 |
Murray Stahl's CME Group Investment FAQs
Murray Stahl first purchased CME Group Inc. (CME) in Q2 2013, acquiring 81,933 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held CME Group Inc. (CME) for 51 quarters since Q2 2013.
Murray Stahl's largest addition to CME Group Inc. (CME) was in Q4 2017, adding 213,998 shares worth $31.25 M.
According to the latest 13F filing for Q4 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 275,611 shares of CME Group Inc. (CME), valued at approximately $75.26 M.
As of the Q4 2025 filing, CME Group Inc. (CME) represents approximately 1.02% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in CME Group Inc. (CME) was 276,773 shares, as reported at the end of Q3 2025.